Search

everythinglearnresearchcommunity

for

Search:↓

Men with a family history of hair loss on their mother's side are more likely to have female pattern hair loss.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Effective treatments for scalp psoriasis include glucocorticosteroids, Vitamin D3 analogs, and combination therapies like calcipotriol and betamethasone dipropionate.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Alopecia causes significant emotional distress and psychological issues, requiring combined skin and mental health treatment.

OCT can effectively examine and reveal details about human hair and scalp conditions.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Collagen makes skin stiff, and preservation methods greatly increase tissue stiffness.

Indian herbal medicine shows promise for treating skin diseases but needs more research to prove effectiveness.

Keratin 79 is linked to liver damage and may help diagnose liver diseases.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

The document is a detailed medical reference on skin and genetic disorders.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

OCT is a reliable, noninvasive way to measure hair thickness.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.